#Glutamate

A new study from Johns Hopkins Medicine uses advanced cryo-electron microscopy (cryo-EM) to show how the neurotransmitter glutamate activates AMPA receptors in the brain. The work deepens our understanding of neural communication and points to potential new treatments for epilepsy and certain intellectual disabilities. Research by Johns Hopkins in collaboration with UTHealth Houston was published in a leading scientific journal.

Neural communication relies on chemical signals between neurons. Glutamate binds to AMPA receptors, triggering electrical signals that propagate through the brain. In this study, scientists captured highly detailed images of receptor function by warming samples to body temperature, a departure from traditional cold-temperature methods. This approach provides more dynamic snapshots of receptor activity under conditions closer to how the brain operates.

In a significant leap toward understanding brain communication, researchers at Johns Hopkins Medicine have harnessed cutting-edge cryo-electron microscopy (cryo-EM) to reveal how glutamate, a key neurotransmitter, activates brain channels. This discovery not only deepens our understanding of neural communication processes but also paves the way for novel treatments for neurological conditions like epilepsy and specific intellectual disabilities source.

The ability of our brains to engage with the environment and learn is fundamentally dependent on the chemical interplay between neurons. At the heart of this communication network is glutamate, a neurotransmitter that binds to AMPA receptors, triggering electrical signals that pass through neurons like messages along a bustling Thai street during rush hour. This study, spearheaded by Johns Hopkins researchers in collaboration with UTHealth Houston scientists, was recently published in the esteemed journal Nature.